|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2009 | ROCHE BAY PLC : Roche drug Avastin fails cancer study, shares fall | RE |
| 2009 | ROCHE BAY PLC : Roche beats recession in first quarter | RE |
NEW YORK (Reuters) - Roche Holding AG is in talks to buy the rest of Genentech Inc it does not already own for about $95 per share, a source familiar with the situation said on Monday.
The two companies began negotiations after Roche raised its offer price to $93 per share on Friday. Roche is trying to acquire the 44 percent of Genentech it does not already own.
"The new price was enough to get both sides to the table," said the source, who was not authorized to speak to the press.
Roche and Genentech declined to comment.
(Reporting by Jessica Hall; editing by Jeffrey Benkoe)
(For more M&A news and our DealZone blog, go to http://www.reuters.com/investing/news/mergers)
ROCE BAY 
By 
